Managing the regulatory landscape of medical devices requires a clear understanding of the EU MDR vs FDA frameworks. Both systems aim to ensure device safety and effectiveness but differ significantly in requirements and processes.
Classification and Risk Levels
The EU MDR and FDA classify devices based on risk, but their classifications vary. The EU MDR uses Classes I, IIa, IIb, and III, while the FDA designates Classes I, II, and III. For example, some devices classified as Class IIb under the EU MDR might fall under Class III for the FDA.
Quality Management Systems
Manufacturers in both regions must implement a compliant Quality Management System. The FDA follows 21 CFR Part 820, while the European Union Medical Device Regulation aligns with ISO 13485:2016. Despite similarities, the nuances in documentation and process make dual compliance complex.
Pre-Market and Post-Market Requirements
The EU MDR mandates CE marking and engagement with Notified Bodies for higher-risk devices. The FDA uses pathways such as 510(k) submissions and Pre-market Approval (PMA). Both systems demand post-market surveillance, but their monitoring mechanisms differ, with the EU adopting EUDAMED and the FDA relying on its database.
Key Considerations for Manufacturers
Manufacturers must tailor their strategies for each market. For example, the EU requires multilingual documentation, while the FDA typically accepts only English. Additionally, reimbursement mechanisms in their medical device regulations differ, with the US leaning on private insurers and CMS, while EU systems vary by country.
Global Compliance with Expert Guidance
Expand confidently into international markets. Get in touch with Vicki Partridge for expert advice on EU MDR and FDA compliance tailored to your needs. Call +61 7 55295508 or email vicki@vickipartridge.com.au.